Preferred Label : F8 protein, human;

MeSH note : RefSeq NM_000132;

CISMeF synonym : recombinant antihemophilic factor VIII; rFVIII; recombinant factor VIII; F8B protein, human; Humate-P; baxter brand of human factor VIII; bayer brand of human factor VIII; bioclate; hemofil; kogenate; monoclate; recombinate; xyntha; antihemophilic factor;

MeSH synonym : coagulation factor VIII, procoagulant component (hemophilia A) protein, human; FVIII protein, human; factor VIII, human; antihemophilic factor human; coagulation factor VIII, human;

MeSH hyponym : Hemofil M; Hemophil; Hemofil HM;

Codes EINECS : 232-593-9;

Is substance : O;

UNII : 839MOZ74GK;

Details


Main resources

You can consult :


https://www.has-sante.fr/portail/jcms/c_2863574/fr/eqwilate
https://www.has-sante.fr/portail/jcms/c_2863574/fr/eqwilate-facteur-von-willebrand-facteur-viii-de-coagulation-humain
2018
false
false
false
false
France
French
evaluation of the transparency committee
drug combinations
treatment outcome
von willebrand factor
F8 protein, human
hemophilia A
von willebrand diseases
hemorrhage
hemorrhage
blood loss, surgical
blood loss, surgical
guidelines for drug use
von willebrand factor and coagulation factor VIII in combination
factor VIII

---
https://www.has-sante.fr/portail/jcms/c_2808586/fr/kovaltry-octocog-alfa-facteur-anti-hemophilique-facteur-viii
https://www.has-sante.fr/portail/jcms/c_2808586/fr/kovaltry
2017
false
false
France
French
evaluation of the transparency committee
octocog alfa
octocog alfa
guidelines for drug use
F8 protein, human
F8 protein, human
hemophilia A
hemorrhage
hemorrhage
factor VIII
factor VIII
treatment outcome
injections, intravenous
recombinant proteins
coagulation factor VIII

---
https://www.has-sante.fr/portail/jcms/c_2733618/fr/kovaltry
2016
false
France
French
evaluation of the transparency committee
octocog alfa
octocog alfa
F8 protein, human
F8 protein, human
hemophilia A
hemorrhage
hemorrhage
factor VIII
factor VIII
treatment outcome
injections, intravenous
recombinant proteins
coagulation factor VIII

---
https://www.ema.europa.eu/medicines/human/EPAR/Iblias
2016
false
United Kingdom
English
French
syndication feed
octocog alfa
octocog alfa
F8 protein, human
F8 protein, human
hemophilia A
hemorrhage
hemorrhage
factor VIII
factor VIII
treatment outcome
drug evaluation
drug approval
drug labeling
injections, intravenous
recombinant proteins
drug storage
drug compounding
coagulation factor VIII
factor VIII
drug evaluation
summary of product characteristics
package leaflet

---
https://www.ema.europa.eu/medicines/human/EPAR/Kovaltry
2016
false
United Kingdom
English
French
syndication feed
F8 protein, human
F8 protein, human
hemophilia A
hemorrhage
hemorrhage
factor VIII
factor VIII
treatment outcome
drug evaluation
drug approval
drug labeling
injections, intravenous
recombinant proteins
drug storage
drug compounding
coagulation factor VIII
factor VIII
drug evaluation
summary of product characteristics
package leaflet

---
http://www.has-sante.fr/portail/jcms/c_2611689/fr/kogenate-bayer
2016
false
France
French
evaluation of the transparency committee
F8 protein, human
hemorrhage
hemophilia A
hemorrhage
factor VIII
treatment outcome
injections, intravenous
coagulation factor VIII

---
https://www.has-sante.fr/portail/jcms/c_2733600/fr/iblias
2016
false
France
French
octocog alfa
octocog alfa
evaluation of the transparency committee
F8 protein, human
F8 protein, human
hemophilia A
hemorrhage
hemorrhage
factor VIII
factor VIII
treatment outcome
injections, intravenous
recombinant proteins
coagulation factor VIII

---
http://www.has-sante.fr/portail/jcms/c_2049886/fr/helixate-nexgen
http://www.has-sante.fr/portail/jcms/c_2049886/fr/helixate-nexgen-octocog-alfa-facteur-viii-de-coagulation-humaine-recombinant
2015
true
France
French
evaluation of the transparency committee
guidelines for drug use
F8 protein, human
F8 protein, human
hemophilia A
hemorrhage
hemorrhage
factor VIII
factor VIII
treatment outcome
injections, intravenous
recombinant proteins
coagulation factor VIII

---
http://www.has-sante.fr/portail/jcms/c_2049892/fr/kogenate-bayer
http://www.has-sante.fr/portail/jcms/c_2049892/fr/kogenate-bayer-octocog-alfa-facteur-viii-de-coagulation-humaine-recombinant
2015
false
France
French
evaluation of the transparency committee
guidelines for drug use
F8 protein, human
hemorrhage
hemophilia A
hemorrhage
factor VIII
factor VIII
treatment outcome
injections, intravenous
coagulation factor VIII
factor VIII

---
http://www.has-sante.fr/portail/jcms/c_2583332/fr/octanate-lv
2015
false
false
false
false
France
French
evaluation of the transparency committee
factor VIII
factor VIII
F8 protein, human
F8 protein, human
hemophilia A
hemorrhage
hemorrhage
coagulation factor VIII
injections, intravenous

---
https://www.ema.europa.eu/medicines/human/EPAR/Voncento
2013
false
United Kingdom
French
English
factor VIII
F8 protein, human
von willebrand factor
drug combinations
von willebrand factor
F8 protein, human
factor VIII
drug approval
treatment outcome
europe
hemophilia A
blood loss, surgical
hemorrhage
hemorrhage
von willebrand diseases
postoperative hemorrhage
postoperative hemorrhage
injections, intravenous
infusions, intravenous
von willebrand factor and coagulation factor VIII in combination
product surveillance, postmarketing
pregnancy
summary of product characteristics
package leaflet
drug evaluation
syndication feed

---
https://www.ema.europa.eu/medicines/human/EPAR/Advate
2012
United Kingdom
French
English
syndication feed
F8 protein, human
F8 protein, human
hemophilia A
hemorrhage
hemorrhage
factor VIII
factor VIII
treatment outcome
drug evaluation
drug approval
drug labeling
infusions, intravenous
pregnancy
breast feeding
drug storage
drug compounding
coagulation factor VIII
factor VIII
drug evaluation
summary of product characteristics
package leaflet

---
https://www.ema.europa.eu/medicines/human/EPAR/Helixate-NexGen
2012
false
United Kingdom
English
French
syndication feed
F8 protein, human
F8 protein, human
hemophilia A
hemorrhage
hemorrhage
factor VIII
factor VIII
treatment outcome
drug evaluation
drug approval
drug labeling
injections, intravenous
recombinant proteins
drug storage
drug compounding
coagulation factor VIII
factor VIII
drug evaluation
summary of product characteristics
package leaflet

---
https://www.ema.europa.eu/medicines/human/EPAR/Kogenate-Bayer
2012
United Kingdom
French
English
syndication feed
Contraindications, Procedure
F8 protein, human
hemorrhage
hemophilia A
hemorrhage
factor VIII
factor VIII
factor VIII
factor VIII
treatment outcome
drug evaluation
injections, intravenous
coagulation factor VIII
drug evaluation
summary of product characteristics
package leaflet
Contraindications, Drug

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68508343
2012
France
summary of product characteristics
package leaflet
F8 protein, human
powders
injections

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69400922
2012
France
summary of product characteristics
package leaflet
injections
F8 protein, human
powders

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63447580
2012
France
summary of product characteristics
package leaflet
F8 protein, human
powders
injections

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66223751
2012
France
summary of product characteristics
package leaflet
injections
F8 protein, human
powders

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63264287
2012
France
summary of product characteristics
package leaflet
F8 protein, human
injections
powders

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63073136
2012
France
summary of product characteristics
package leaflet
powders
F8 protein, human
injections

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct032423.pdf
http://www.has-sante.fr/portail/display.jsp?id=c_400845
2006
France
French
coagulation factor VIII
F8 protein, human
factor VIII
infusions, intravenous
child
recombinant proteins
hemorrhage
hemorrhage
hemophilia A
treatment outcome
F8 protein, human
factor VIII
factor VIII
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/display.jsp?id=c_245565
2005
France
French
hemorrhage
hemorrhagic disorders
factor VIII
recombinant proteins
coagulation factor VIII
factor VIII
F8 protein, human
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/display.jsp?id=c_245127
2004
France
French
factor VIII
F8 protein, human
coagulation factor VIII
guidelines for drug use

---
Nous contacter.
30/04/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.